Respirology
RSV Prevention for All Infants
This is a 60-minute webinar for Canadian HCPs. Due to the limited therapeutic options available to manage RSV disease, the goal is to provide education on disease prevention. This webinar is designed to provide practical information on passive immunization options available in Canada, with a focus on the newly authorized long-acting monoclonal antibody nirsevimab, and the maternal RSVpref vaccine. Utilizing case studies, the webinar will review how to apply NACI's recommendations for building towards a universal RSV immunization program for all infants.
DURATION
1 hr
PROFESSION
Physician, Nursing, Pharmacy, Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2025-04-06
Respiratory syncytial virus (RSV) is one of the most common respiratory viruses in infants and young children globally, infecting almost all children by two years of age. RSV is also the leading cause of infant hospitalizations in Canada, resulting in significant disease burden and impacts on the Canadian health system. Palivizumab, a short-acting monoclonal antibody, has been used for over 20 years in RSV immunizations programs; however, its use is limited to infants at highest risk of severe disease. In 2023, two new products were authorized by Health Canada: nirsevimab, a long-acting monoclonal antibody, and RSVpref, a maternal vaccine, both with broader indications to protect all infants against RSV. Considering the substantial burden of disease in all infants and the impact of RSV on the Canadian health system, NACI recommends building towards a universal RSV immunization program.
This program has received an unrestricted educational grant or in-kind support from Sanofi.
Learning objectives
Upon completion of this program, participants will be able to:
- Describe the prevalence and burden of RSV disease in all infants
- Summarize NACI guidance and supporting evidence on passive immunization for RSV
- Implement an RSV prevention order set to support clinical practice
# of credits: 0 
Duration: 1 hr FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
